A package of bills moving through the Michigan Senate could add additional restrictions to embryonic stem cell research in the state, much to the dismay of University researchers and student groups alike.
Diseases like Cancer (Leukemia, lymphoma, Myeloma), Blood disorders (Thalessemia, sickle cell anemia, Fanconi anemia) and Auto Immune Deficiency have successfully been treated using UCB stem cells. “With 20 years of human safety, umbilical cord blood …
Larry Goldstein, M.D. Larry Goldstein, M.D., will discuss and sign his book, “Stem Cells for Dummies” at 7 p.m. March 2 at The Book Works in the Flower Hill Promenade, 2670 Via de la Valle, Del Mar. Goldstein is a professor of cellular and molecular medicine at UCSD School of Medicine, and the director of UCSD’s Stem Cell Program, as well as investigator at the Howard Hughes Medical Institute …
Working with mice, Johns Hopkins scientists who tested drugs intended to halt growth of brain cancer stem cells – a small population of cells within tumors that perpetuate cancer growth – conclude that blocking these cells may be somewhat effective, but more than one targeted drug attack may be needed to get the job done.
California’s stem cell research funding agency has launched an online stem cell curriculum for high school students. The California Institute for Regenerative Medicine , based in San Francisco, said the course materials and resources on its “Stem …
UCLA AIDS Institute researchers successfully removed CCR5 — a cell receptor to which HIV-1 binds for infection but which the human body does not need — from human cells. Individuals who naturally lack the CCR5 receptor have been found to be …
Researchers at UTHealth … modified adult stem cells into an injured spinal cord can help restore the electrical pathways associated with movement. The results are published in the Feb. 24 issue of the Journal of Neuroscience. In spinal cord injury …
OKLAHOMA CITY — A new adult stem cell research center to be located at the University of Oklahoma Health Sciences Center has been approved by the Oklahoma Tobacco Settlement Endowment Trust. Researchers say the new Oklahoma Center for Adult Stem …
Interest rates to remain low, but sales of new homes fell Columbia-based Osiris Therapeutics Inc. reported several breakthroughs in clinical trials of its stem-cell therapy and improved fourth-quarter earnings on Wednesday. The biotechnology company said fourth-quarter net income rose to $15.7 million on revenue of $10.7 million, compared to a net loss of $7.8 million on revenue of $6.1 million …